Wells Fargo & Company Anavex Life Sciences Corp. Put Options Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AVXL
# of Institutions
186Shares Held
29.1MCall Options Held
894KPut Options Held
821K-
Black Rock Inc. New York, NY6.39MShares$55.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$40.8 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$16.3 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.13MShares$9.89 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $680M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...